GDRX Earnings & Financial Statements
GoodRx Holdings, Inc.
$3.51
+$0.13(+3.70%)
65
Overall
75
Value
80
Tech
42
Quality
Market Cap
$1.15B
Volume
1.90M
52W Range
$1.77 - $4.33
Target Price
$3.95
GDRX earnings and financial statements: GoodRx Holdings, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
GDRX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $796.85M | $792.32M | $750.26M | $766.55M | $745.42M |
| Cost of revenue | $57.60M | $48.22M | $66.92M | $65.08M | $46.72M |
| Operating income | $87.49M | $65.85M | -$27.01M | $1.74M | $13.41M |
| EBITDA | $190.14M | $160.60M | $112.21M | $68.60M | $48.00M |
| Net income | $30.44M | $16.39M | -$8.87M | -$32.83M | -$25.25M |
| EPS (diluted) | $0.09 | $0.04 | $-0.02 | $-0.08 | $-0.06 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.40B | $1.39B | $1.59B | $1.60B | $1.61B |
| Total liabilities | $787.80M | $663.41M | $826.84M | $789.80M | $775.95M |
| Shareholders’ equity | $616.26M | $724.66M | $761.96M | $814.83M | $831.68M |
| Cash and equivalents | $261.82M | $448.35M | $672.30M | $757.16M | $941.11M |
| Long-term debt | $533.05M | $532.75M | $696.11M | $705.93M | $689.45M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $167.90M | $183.89M | $138.29M | $146.78M | $178.78M |
| Capital expenditure | -$74.02M | -$70.35M | -$55.77M | -$55.21M | -$34.46M |
| Free cash flow | $93.88M | $113.55M | $82.53M | $91.57M | $144.32M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GDRX | $3.51 | +3.7% | 1.90M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |